Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2002

Humira(Adalimumab)AbbVie Inc. logoABBV

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by AbbVie Inc.

$208.8M

Medicare cost, 2024

Medicare drug plans spent $208.8 million on Humira (adalimumab) in 2024, for 25,512 prescriptions and refills filled by 3,911 patients. Spending fell 19% from 2023 to 2024. At about $8,183 per prescription it is a high-cost drug. California accounts for the most spending ($23.0 million, 11% of the total).

Medicare cost, 2024

$208.8M

-19.0% from 2023

Prescriptions

26K

$8,182.82 per claim

Patients

3,911

3,737 prescribers

Total spending, 2024

$208.9M

$53,401.11 per patient

Questions and answers

How much does Medicare spend on Humira?

Medicare prescription drug plans paid $208.8M for Humira in 2024, for 25,512 prescriptions and refills to 3,911 patients (down 19.0% from 2023). The average cost per claim was $8,182.82.

Which state spends the most on Humira?

California had the highest Medicare cost for Humira in 2024: $23.0M for 2,946 claims, followed by New York ($14.4M).

Who prescribes Humira the most?

Charles King, rheumatology in Tupelo, MS, had the highest Medicare cost for Humira in 2024: 213 claims costing $1.4M.

Who makes Humira?

Humira is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Humira was $208.9M in 2024, after a high of $383.6M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Humira, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Charles King Tupelo, MSRheumatology21328$1.4M
Sony Paul Carrollton, TXNurse Practitioner8615$984K
Maria A Bacalao Dallas, TXRheumatology8416$726K
David H Stone Martinez, CAFamily Practice65Under 11$640K
Maria L Laynes Mt Pleasant, MIInternal Medicine69Under 11$584K
Marie Y Maitre Dallas, TXPhysician Assistant7014$500K
Renee C Moenning Indianapolis, INRheumatology31Under 11$455K
Aldona Ziolkowska High Point, NCRheumatology53Under 11$415K
Mark Robbins Boston, MARheumatology50Under 11$401K
John P Cotter Travelers Rest, SCFamily Practice59Under 11$400K
Aruna Venkatesan Redwood City, CADermatology28Under 11$357K
Stephen J Melson Forest City, NCGastroenterology26Under 11$357K
Roy C Sampson Lowell, ARRheumatology52Under 11$350K
Timothy R Palmer Lansing, MIPhysician Assistant26Under 11$342K
Hazem Zebda Jackson, MIInternal Medicine45Under 11$339K
Robert P Lagrone Nashville, TNRheumatology19Under 11$325K
Ashley Goble Ashland, KYNurse Practitioner39Under 11$318K
Patrick K Timms Pueblo, CORheumatology24Under 11$317K
Elvin R Garcia McAllen, TXRheumatology45Under 11$305K
Steven H Stern Louisville, KYRheumatology23Under 11$302K
Roger R Wang San Francisco, CAAllergy/ Immunology50Under 11$301K
William C Palmer Warner Robins, GANurse Practitioner25Under 11$294K
Veronika Sharp Palo Alto, CARheumatology45Under 11$291K
Emma G Diiorio Rockville, MDRheumatology26Under 11$288K
Therese F Posas-Mendoza Covington, LARheumatology25Under 11$282K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20225,06838,4945,598$298.0M
20234,38630,6074,742$257.6M
20243,73725,5123,911$208.8M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Abbvie US LLCABBV logoABBV25,521$208.9M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
23
RxNorm concept IDs
1594352, 1594357, 1594358, 1655726, 1655728
Application numbers
BLA125057

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube